Tale of two halves, as we had our first harvest in June and began processing material from our farm in August. Note the H2 change.
Free cash flow of $(1.1) million for FY 2025, compared to $(7.3) million in FY 2024, with free cash flow of $1.3 million in H2 2025, compared to $(2.4) million in H1 2025, an improvement of 155.0%
Hope you caught this. $PLRZ files its 20-F annual report.
A key technical level is now being tested post-filing.
Monitor the volume reaction closely for confirmation.
Risk management is paramount here.
Interesting divergence: $EML settles class action, yet options flow suggests positioning for a move.
The court approval removes an overhang, but market positioning hints at anticipated volatility.
Scale in gradually.
Interesting divergence:
$AMZN −1.38%, $META −1.84%, and $MSFT −2.68% show broad tech pressure, yet market data suggests underlying strength as royalty firms like Elemental post record +128% revenue beats. 👇
🚨 $ROMA surging to $8.01 +35.08%.
Speed of move is extreme.
Capital allocation improving.
$QQQ notice received, but shares continue trading.
High-volatility situation unfolding.
You use Claude every day and think it's incredible.
Every time you use Claude, you're paying infrastructure costs to Amazon, Google or Microsoft. $AMZN $GOOGL $MSFT
Anthropic has committed to paying at least $80B to those three companies just for cloud through 2029.
In 2027, it could transfer another $6.4B extra in revenue share.
Amazon owns 15% of Anthropic ($10B invested), Google owns 14%, and Microsoft just joined as an investor in the latest round.
Current valuation: $380B , Series G closed this month.
The model is brilliant, yes.
But the infrastructure running it is controlled by the same players as always.
Next time you use an "alternative" AI... remember who's taking the money underneath.
Amazon, Google and Microsoft aren't losing the AI race.
They're funding it.
Is $CNXC's Q1 2026 report a catalyst for options flow?
Concentrix just released its fiscal first-quarter results. The data suggests a potential inflection point.
Strategy: Scale in gradually.
Market data suggests a clear rotation into mega-cap tech, with $AMZN surging +2.32% and $AAPL up +1.41%, as the sector rallies on execution of long-term AI & chip visions like 'Terafab', while $MSFT holds steady, gaining +0.30%.
FED TALK (AKA: CLEAR AS MUD): $SPY
🔹 Goolsbee: Could cut rates… could hike… depends on literally everything
🔹 Warns oil shocks = stagflation risk
🔹 Still thinks rates drift lower eventually
🔹 Miran: Wants ~100bps cuts this year
🔹 Says don’t overreact to oil spikes
🔹 Admits hikes possible, but not his base case
🚨 $BIAF surges to $4.68, up 71.43%.
1. Major catalyst: New case study for CyPath® Lung demonstrates clinical utility in patient care.
2. The non-invasive test provided actionable results, helping avoid costly procedures.
3. 💭
I aped $AI at a $33k market cap and strategically shared it with my community, highlighting its early-entry edge and strong upside potential.
CA:
B7GoreQ4cp5Re9xqv1WNYmMKxA3fmFhccAU6SPRTpump
#bbvipks4#memecoin#Web3#CryptoCommunity
👀 Watching $AMZN $DIS $PSKY...
Q: Did a major film release test key technical levels?
A: Yes. $AMZN's "Project Hail Mary" delivered a box office hit, impacting related stocks.
Watch support levels as the market digests the news.